Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

109 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Prospective assessment of antidonor cellular alloreactivity is a tool for guidance of immunosuppression in kidney transplantation.
Bestard O, Cruzado JM, Lucia M, Crespo E, Casis L, Sawitzki B, Vogt K, Cantarell C, Torras J, Melilli E, Mast R, Martinez-Castelao A, Gomà M, Reinke P, Volk HD, Grinyó JM. Bestard O, et al. Among authors: melilli e. Kidney Int. 2013 Dec;84(6):1226-36. doi: 10.1038/ki.2013.236. Epub 2013 Jun 19. Kidney Int. 2013. PMID: 23783240 Free article.
Preformed frequencies of cytomegalovirus (CMV)-specific memory T and B cells identify protected CMV-sensitized individuals among seronegative kidney transplant recipients.
Lúcia M, Crespo E, Melilli E, Cruzado JM, Luque S, Llaudó I, Niubó J, Torras J, Fernandez N, Grinyó JM, Bestard O. Lúcia M, et al. Among authors: melilli e. Clin Infect Dis. 2014 Dec 1;59(11):1537-45. doi: 10.1093/cid/ciu589. Epub 2014 Jul 21. Clin Infect Dis. 2014. PMID: 25048845 Free PMC article.
Pre-transplant donor-specific T-cell alloreactivity is strongly associated with early acute cellular rejection in kidney transplant recipients not receiving T-cell depleting induction therapy.
Crespo E, Lucia M, Cruzado JM, Luque S, Melilli E, Manonelles A, Lloberas N, Torras J, Grinyó JM, Bestard O. Crespo E, et al. Among authors: melilli e. PLoS One. 2015 Feb 17;10(2):e0117618. doi: 10.1371/journal.pone.0117618. eCollection 2015. PLoS One. 2015. PMID: 25689405 Free PMC article.
De novo use of a generic formulation of tacrolimus versus reference tacrolimus in kidney transplantation: evaluation of the clinical results, histology in protocol biopsies, and immunological monitoring.
Melilli E, Crespo E, Sandoval D, Manonelles A, Sala N, Mast R, Padulles A, Grinyo JM, Bestard O, Cruzado JM. Melilli E, et al. Transpl Int. 2015 Nov;28(11):1283-90. doi: 10.1111/tri.12626. Epub 2015 Jul 14. Transpl Int. 2015. PMID: 26088437 Free article.
Posttransplant peripheral blood donor-specific interferon-γ enzyme-linked immune spot assay differentiates risk of subclinical rejection and de novo donor-specific alloantibodies in kidney transplant recipients.
Crespo E, Cravedi P, Martorell J, Luque S, Melilli E, Cruzado JM, Jarque M, Meneghini M, Manonelles A, Donadei C, Lloberas N, Gomà M, Grinyó JM, Heeger P, Bestard O. Crespo E, et al. Among authors: melilli e. Kidney Int. 2017 Jul;92(1):201-213. doi: 10.1016/j.kint.2016.12.024. Epub 2017 Mar 6. Kidney Int. 2017. PMID: 28274484 Free PMC article.
109 results